
Published On: Nov 2023
Published On: Nov 2023
According to Business Market Insights’ research, the Europe clinic casting and splinting products market was valued at US$ 424.57 million in 2022 and is expected to reach US$ 624.42 million by 2030, registering a CAGR of 4.9% from 2022 to 2030. Rising prevalence of musculoskeletal conditions and high prevalence of age-related orthopedic disorders are the critical factors attributed to the Europe clinic casting and splinting products market expansion.
The rapid development of 3D printing implies fast penetration 3D printing techniques into the healthcare system, especially for treating fractures. In rehabilitation tool manufacturing, 3D printing technology is applied to orthopedic cast fabrication to create patient-specific features with an appropriate fit and a ventilated structure. The novel casting technology heals the fracture effectively without casting complications. The 3D-printed cast is customized and lightweight.
Patient-specific and 3D-printed casts develop proper fit according to the shape of the injured arm. Thus, the risk of stress concentration can be reduced since large contact areas are created. 3D printing makes the fabrication process simpler and in shorter period, especially in a customized design. On that account, the application of 3D printing in biomedical engineering is growing and promising to be practiced in the future. Also, the customizable hand cast made by using 3D printing technique is reliable and provides comfort and satisfaction to the patients. 3D printing is an evolving technology that has a potential application in treating pediatric forearm fractures. These factors can lead to better patient compliance. The 3D-printed cast proved to be superior in terms of satisfaction, comfort, and perceived function as compared to the fiberglass. Thus, the above-mentioned factors would create significant opportunities for the Europe clinic casting and splinting products market in the coming years.
On the contrary, complications related to casting and splinting hamper the Europe clinic casting and splinting products market.
Based on product, the Europe clinic casting and splinting products market is segmented into casting and splinting. The casting segment held 63.4% share of Europe clinic casting and splinting products market in 2022, amassing US$ 269.22 million. It is projected to garner US$ 387.49 million by 2030 to expand at 4.7% CAGR during 2022–2030. The casting is sub-segmented into casts, tapes, cutters, and casting accessories. The splinting segment is further segmented into splints and splinting accessories.
Based on application, the Europe clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. The acute fractures segment held 48.4% share of Europe clinic casting and splinting products market in 2022, amassing US$ 205.29 million. It is projected to garner US$ 308.75 million by 2030 to expand at 5.2% CAGR during 2022–2030.
Based on material, the Europe clinic casting and splinting products market is segmented into Plaster of Paris, fiberglass, and others. The Plaster of Paris segment held 46.1% share of Europe clinic casting and splinting products market in 2022, amassing US$ 195.75 million. It is projected to garner US$ 282.96 million by 2030 to expand at 4.7% CAGR during 2022–2030.
Based on country, the Europe clinic casting and splinting products market has been categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 25.6% share of Europe Clinic Casting and Splinting Products Market in 2022. It was assessed at US$ 108.73 million in 2022 and is likely to hit US$ 157.48 million by 2030, exhibiting a CAGR of 4.7% during 2022–2030.
Key players operating in the Europe clinic casting and splinting products market are 3M Co, DeRoyal Industries Inc, Enovis Corp, Essity AB, Ossur hf, Performance Health Holding Inc, and Zimmer Biomet Holdings Inc, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com